Insights

Strong Funding Backing PetMedix has secured a significant Series B investment of $37 million from notable investors such as Tencent, Cambridge Innovation Capital, and Digitalis Ventures, indicating strong financial support and growth potential. This presents opportunities to offer innovative solutions that align with their expanding pipeline and clinical development ambitions.

Innovative Platform Focus The company's proprietary Ky9 platform for developing species-specific therapeutic antibodies highlights a focus on cutting-edge biotech technology. Sales opportunities exist for advanced biotech tools, data analytics, and related technologies that can enhance their research and development capabilities.

Strategic Partnerships Partnering with global pharmaceutical leader Boehringer Ingelheim demonstrates their openness to collaborative development. This paves the way for joint ventures, licensing opportunities, and product co-development collaborations with suppliers of complementary therapeutics or diagnostic solutions.

Market Expansion Potential With a focus on underserved clinical areas in veterinary medicine and a pipeline ready for clinical advancement, there are opportunities to introduce specialized healthcare solutions, regulatory consulting, and manufacturing services tailored to veterinary biotech growth.

Recognition and Visibility Award recognition as the best start-up in the global Animal Pharm Awards positions PetMedix as a credible partner within the veterinary biotech landscape, opening doors for networking, strategic alliances, and targeted sales channels within the sector.

Similar companies to PetMedix

PetMedix Tech Stack

PetMedix uses 8 technology products and services including WordPress, Font Awesome, Twemoji, and more. Explore PetMedix's tech stack below.

  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • Twemoji
    Font Scripts
  • Google Fonts API
    Font Scripts
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • MediaElement.js
    Video Players
  • Google Analytics
    Web Analytics

Media & News

PetMedix's Email Address Formats

PetMedix uses at least 1 format(s):
PetMedix Email FormatsExamplePercentage
First.Last@petmedix.co.ukJohn.Doe@petmedix.co.uk
95%
First.L@petmedix.co.ukJohn.D@petmedix.co.uk
5%

Frequently Asked Questions

Where is PetMedix's headquarters located?

Minus sign iconPlus sign icon
PetMedix's main headquarters is located at Babraham, England cb22 3fh United Kingdom. The company has employees across 2 continents, including EuropeNorth America.

What is PetMedix's official website and social media links?

Minus sign iconPlus sign icon
PetMedix's official website is petmedix.co.uk and has social profiles on LinkedIn.

What is PetMedix's SIC code NAICS code?

Minus sign iconPlus sign icon
PetMedix's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PetMedix have currently?

Minus sign iconPlus sign icon
As of February 2026, PetMedix has approximately 41 employees across 2 continents, including EuropeNorth America. Key team members include Chief Product Development Officer: D. L.Senior Scientist, Ngs Pipeline: C. C.Research Associate: S. L.. Explore PetMedix's employee directory with LeadIQ.

What industry does PetMedix belong to?

Minus sign iconPlus sign icon
PetMedix operates in the Biotechnology Research industry.

What technology does PetMedix use?

Minus sign iconPlus sign icon
PetMedix's tech stack includes WordPressFont AwesomeTwemojiGoogle Fonts APIPHPYoast SEOMediaElement.jsGoogle Analytics.

What is PetMedix's email format?

Minus sign iconPlus sign icon
PetMedix's email format typically follows the pattern of First.Last@petmedix.co.uk. Find more PetMedix email formats with LeadIQ.

How much funding has PetMedix raised to date?

Minus sign iconPlus sign icon
As of February 2026, PetMedix has raised $37M in funding. The last funding round occurred on Sep 08, 2021 for $37M.

When was PetMedix founded?

Minus sign iconPlus sign icon
PetMedix was founded in 2017.

PetMedix

Biotechnology ResearchEngland, United Kingdom11-50 Employees

PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. We are using the highest quality science to make the therapies our pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, we are applying the cutting edge of science to bring breakthroughs for the animals we love and care for. 

PetMedix is taking the experience of its founding team, and decades of human clinical research, to build platforms that generate fully species-specific, naturally-generated therapeutic antibodies. These platforms have been designed to generate a repertoire of antibodies as diverse as the companion animal immune systems on which they are based. These platforms can then be used to develop a broad pipeline of our own veterinary medicines to target under-served clinical areas that represent excellent market opportunities. 

We are actively recruiting so please get in touch if you wish to join our hard-working and talented team.

Section iconCompany Overview

Headquarters
Babraham, England cb22 3fh United Kingdom
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $37M

    PetMedix has raised a total of $37M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2021 in the amount of $37M.

  • $1M

    PetMedix's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $37M

    PetMedix has raised a total of $37M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2021 in the amount of $37M.

  • $1M

    PetMedix's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.